Abstract:Background: Podophyllotoxin is a potent cytotoxic agent and serves as a useful lead compound for the development of antitumor drugs. Several podophyllotoxin-derived antitumor agents, including etoposide, are currently in clinical use; however, their therapeutic efficacy is often limited due to side effects and the development of resistance by cancer cells. Previous studies have shown that 4β-1,2,3-triazole derivatives of podophyllotoxin exhibit more potent anticancer activity and better binding to topoisomerase-II than etoposide. The effect of dimerization of such derivatives on the anticancer activity has not been studied. Methods: Two moieties of podophyllotoxin were linked at the C-4 position via 1,2,3-triazole rings to give a series of novel dimeric podophyllotoxin derivatives. 4β-Azido-substituted podophyllotoxin derivatives (23 and 24) were coupled with various dipropargyl functionalized linkers by utilizing the copper-catalyzed azide-alkyne cycloaddition (CuAAC) reaction to provide dimeric products in very good yield. The in vitro anticancer activity of the synthesized compounds was evaluated by MTT assay against a panel of five human cancer cell lines (HL-60, SMMC-7721, A-549, MCF-7, and SW480). The normal BEAS-2B (lung) cell line was also included for study in order to evaluate the cancer selectivity of the most active compound as compared with normal cells. Results: A group of 16 dimeric podophyllotoxin derivatives with different linkers were synthesized and structurally characterized. Most compounds do not show significant cytotoxicity (IC50 > 40 mM) against all five cancer cell lines. However, one compound (29) which bears a perbutyrylated glucose residue on the glycerol linker is highly potent against all five cancer cell lines tested, with IC50 values ranging from 0.43 to 3.50 μM. This compound (29) also shows good selectivity towards cancer cell lines as compared with the normal BEAS-2B (lung) cell line, showing selectivity indexes from 4.4 to 35.7. Conclusion: The anticancer activity of dimeric podophyllotoxin derivatives is generally speaking not improved as compared to their monomeric counterparts, and the potency of these dimeric derivatives can be largely affected by the nature of the linker between the two moieties. Among the synthesized derivatives, compound 29 is significantly more cytotoxic and selective towards cancer cells than etoposide and cisplatin, which are currently in clinical use. Compound 29 is a promising anticancer drug and needs further studies.

Synthesis and Anticancer Activity of 4 Β -Triazole-podophyllotoxin Glycosides

Synthesis And Anticancer Activity Of Glucosylated Podophyllotoxin Derivatives Linked Via 4 Beta-Triazole Rings

Synthesis of New Spin Labeled Derivatives of Podophyllotoxin As Potential Anticancer Agents

Synthesis And Evaluation Of New Podophyllotoxin Derivatives With In Vitro Anticancer Activity

Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.

Synthesis and Evaluation of Novel Podophyllotoxin Derivatives As Potential Antitumor Agents.

Design, Synthesis, and Cytotoxicity of Perbutyrylated Glycosides of 4Β-Triazolopodophyllotoxin Derivatives

Synthesis And Cytotoxic Activity On Human Cancer Cells Of Carbamate Derivatives Of 4 Beta-(1,2,3-Triazol-1-Yl)Podophyllotoxin

Synthesis and antitumor activity of novel per-butyrylated glycosides of podophyllotoxin and its derivatives.

Synthesis and Antitumor Activity of 4β-(1,2,3-Triazol-1-yl) podophyllotoxins

Semi-synthesis and biological evaluation of 1,2,3-triazole-based podophyllotoxin congeners as potent antitumor agents inducing apoptosis in HepG2 cells.

Synthesis and Biological Evaluation of 4Β-N-acetylamino Substituted Podophyllotoxin Derivatives As Novel Anticancer Agents.

Synthesis, cytotoxicity, and molecular docking of methylated (–)-epigallocatechin-3-gallate-4β-triazolopodophyllotoxin derivatives as novel antitumor agents

Synthesis of Novel Spin-Labeled Podophyllotoxin Derivatives As Potential Antineoplastic Agents: Part XXV

Synthesis and anticancer activity of dimeric podophyllotoxin derivatives

Synthesis and antitumor activity of camptothecin- 4β-triazolopodophyllotoxin conjugates

Synthesis and Antitumor Activity of 2-Aryl-1, 2, 4-Triazolo[1, 5-A] Pyridine Derivatives

Synthesis of Novel 4Β-(1, 2, 3-Triazol-1-yl) Podophyllotoxins As Potential Antitumor Drugs

Design, Synthesis, and Biological Evaluation of Novel Biotinylated Podophyllotoxin Derivatives as Potential Antitumor Agents

Click Glycosylation for the Synthesis of 1,2,3-Triazole-Linked Picropodophyllotoxin Glycoconjugates and Their Anticancer Activity

Syntheses and structure-activity relationship of podophyllotoxin derivatives as potential anticancer drugs